Preferred Label : parathyroid hormone-related protein;
MeSH definition : A ubiquitously expressed, secreted protein with bone resorption and renal calcium
reabsorption activities that are similar to PARATHYROID HORMONE. It does not circulate
in appreciable amounts in normal subjects, but rather exerts its biological actions
locally. Overexpression of parathyroid hormone-related protein by tumor cells results
in humoral calcemia of malignancy.;
MeSH synonym : hormone-related protein, parathyroid; hypercalcemic hormone of malignancy; parathyroid hormone like protein; parathyroid hormone related peptide; parathyroid hormone-like protein; parathyroid hormone-related peptide; pth like protein; pth-related peptide; pthrp; tumor hypercalcemic factor; hypercalcemic factor, tumor; pth like tumor factor; pth-like protein; parathyroid hormone like tumor factor; pth related peptide; parathyroid hormone related protein;
MeSH annotation : see SCR for organism specific terms;
Is substance : O;
Origin ID : D044162;
UMLS CUI : C0070099;
Allowable qualifiers
- Currated CISMeF NLP mapping
- Pharmacological action(s)
- Record concept(s)
- Related MeSH Supplementary Concept(s)
- See also
- Semantic type(s)
- UMLS correspondences (same concept)
A ubiquitously expressed, secreted protein with bone resorption and renal calcium
reabsorption activities that are similar to PARATHYROID HORMONE. It does not circulate
in appreciable amounts in normal subjects, but rather exerts its biological actions
locally. Overexpression of parathyroid hormone-related protein by tumor cells results
in humoral calcemia of malignancy.
https://www.ema.europa.eu/en/medicines/human/EPAR/eladynos
2023
false
false
false
Netherlands
French
English
treatment outcome
drug evaluation
abaloparatide
abaloparatide
summary of product characteristics
package leaflet
syndication feed
abaloparatide
drug approval
europe
osteoporosis, postmenopausal
osteoporotic fractures
injections, subcutaneous
bone density conservation agents
bone density conservation agents
product surveillance, postmarketing
drug interactions
drug evaluation, preclinical
parathyroid hormone-related protein
---
